Peter A. Campochiaro

Peter A. Campochiaro

Ophthalmology

1800 Orleans Street, Maumenee Lobby
Maumenee Lobby
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 151 publications

Suprachoroidal Delivery of Anti-Angiogenic Peptide Microparticles Enables Sustained Activity with Favorable Ocular Safety.

Suprachoroidal Delivery of Anti-Angiogenic Peptide Microparticles Enables Sustained Activity with Favorable Ocular Safety.

Journal: bioRxiv : the preprint server for biology

Published: July 10, 2026

Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa.

Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Suppression of choroidal neovascularization by nonviral gene transfer of pigment epithelium-derived factor.

Suppression of choroidal neovascularization by nonviral gene transfer of pigment epithelium-derived factor.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 08, 2025

A gel-forming antioxidant eye drop for photoreceptor protection in retinitis pigmentosa.

A gel-forming antioxidant eye drop for photoreceptor protection in retinitis pigmentosa.

Journal: Drug delivery and translational research

Published: July 16, 2025

Sustained Suppression of VEGF for Treatment of Retinal and Choroidal Vascular Diseases.

Sustained Suppression of VEGF for Treatment of Retinal and Choroidal Vascular Diseases.

Journal: American journal of ophthalmology

Published: April 11, 2025

Structural Updates to the Implant and Refill Needle of the Port Delivery Platform.

Structural Updates to the Implant and Refill Needle of the Port Delivery Platform.

Journal: Translational vision science & technology

Published: April 07, 2025

Stair-Case/Honeycomb Maculopathy in Alport Syndrome: A Case Report.

Stair-Case/Honeycomb Maculopathy in Alport Syndrome: A Case Report.

Journal: Case reports in ophthalmology

Published: March 31, 2025

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial.

Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial.

Journal: JAMA ophthalmology

Published: March 06, 2025

Gene therapy for AMD: better as an adjuvant than a replacement - Authors' reply.

Gene therapy for AMD: better as an adjuvant than a replacement - Authors' reply.

Journal: Lancet (London, England)

Published: January 14, 2025

Suprachoroidal Delivery of Viral and Nonviral Vectors for Treatment of Retinal and Choroidal Vascular Diseases.

Suprachoroidal Delivery of Viral and Nonviral Vectors for Treatment of Retinal and Choroidal Vascular Diseases.

Journal: American journal of ophthalmology

Published: September 30, 2024

Bispecific receptor decoy proteins block ocular neovascularization via simultaneous blockade of vascular endothelial growth factor A and C.

Bispecific receptor decoy proteins block ocular neovascularization via simultaneous blockade of vascular endothelial growth factor A and C.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 26, 2024

Characterization of Macular Fundus Autofluorescence Changes in Patients with Retinitis Pigmentosa.

Characterization of Macular Fundus Autofluorescence Changes in Patients with Retinitis Pigmentosa.

Journal: Ophthalmic research

Published: August 06, 2024

Showing 1-12 of 151

Last Updated: 09/26/2026